Neurosurgery News and Research

RSS

UVA acquires Extend to broaden the potential for Gamma Knife Perfexion

Patients with overly large benign skull base tumors, lesions too close to critical anatomy and those with multiple brain metastases are among those who will benefit first from a new "frameless" device for use with Leksell Gamma Knife Perfexion systems.

From Elekta 18 Dec 2009

NREF supports new post-residency fellowship grant program

The NREF has reached an agreement with Codman & Shurtleff, Inc. to provide funding to the NREF in support of the Foundation's new post-residency fellowship grant program.

16 Dec 2009

CHUM neurosurgeon raises funds for epilepsy research

On January 8, 2010, CHUM neurosurgeon Dr. Alain Bouthillier will leave for Argentina, where he will brave the 6,962-metre heights (over 22,840 feet) of Mount Aconcagua. Dr. Bouthillier's climb is intended to raise public awareness about epilepsy and raise funds for further research on the illness.

15 Dec 2009

New brain metastases treatment guidelines

New treatment guidelines for patients with brain metastases are now available from the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS).

10 Dec 2009

St. Luke's Hospital acquires computer-assisted surgery system from BrainLAB

BrainLAB, a manufacturer of software-driven systems for targeted, less-invasive medical treatments, announced today that St. Luke's Hospital in Cedar Rapids, Iowa, has acquired VectorVision® flex, a powerful computer-assisted surgery (CAS) system featuring Digital Lightbox© with TraumaCad(TM), a pre-operative planning and digital templating software solution.

9 Dec 2009

High-flow oxygen appears to be more effective in treating cluster headaches

Patients with a cluster headache, which is characterized by bouts of excruciating pain usually near the eye or temple, were more likely to report being pain-free within 15 minutes of treatment with high-flow oxygen than patients who received a placebo treatment, according to a study in the December 9 issue of JAMA.

9 Dec 2009

New Acesis software platform improves patient safety and quality care

Acesis, the enterprise software company focused on healthcare performance improvement, today announced results from its first six months of service for the University of California, San Francisco (UCSF) Division of Hospital Medicine.

9 Dec 2009

Texas Sinus Center offers FinESS Sinus Treatment to break the cycle of chronic sinusitis

Dr. James Atkins, founder of the Texas Sinus Center (www.texassinuscenter.com), today announced he is now offering the FinESS® Sinus Treatment, a minimally invasive treatment that breaks the cycle of chronic sinusitis (CRS) at Foundation Surgical Hospital of San Antonio.

8 Dec 2009

Oxygen Biotherapeutics commences enrollment in clinical trial of Oxycyte emulsion for TBI

Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.

5 Dec 2009

Appropriate toys for children: Suggestions from doctors and experts

With the excitement of the holidays, parents and relatives eagerly purchase the hottest toys and latest items for their children. But it's during the hustle and bustle of the season that many fail to buy age appropriate gifts and they tend to disregard warnings on these toys and gifts when it comes to ensuring safety.

5 Dec 2009

DTI helps identify distorted nerve fiber bundles around brain tumors in thalamic JPA children

A new study published this week in the Journal of Neurosurgery: Pediatrics finds that operative plans for removing Juvenile Pilocytic Astrocytoma, or JPA, tumors in the thalamus of the brain can be augmented with Diffusion Tensor Imaging, or DTI. The sensitivity of DTI imaging allows for the visualization of nerve fiber bundles in the brain.

5 Dec 2009

Benign tumors in children can be augmented with Diffusion Tensor Imaging

5 Dec 2009

Cyberonics' FDA-approved VNS Therapy to be featured at the AES meeting

Cyberonics, Inc. announced today that Vagus Nerve Stimulation (VNS) Therapy, the only FDA-approved implantable medical device for the treatment of refractory epilepsy, will be featured in 14 presentations at the American Epilepsy Society's (AES) Annual Meeting, taking place December 4-8 at the Hynes Convention Center in Boston, Massachusetts.

4 Dec 2009

New research trial to study the impact of exercise on Parkinson's patients

Officials at the new Muhammad Ali Parkinson Center at Barrow Neurological Institute announced today the center's participation in a novel Parkinson's study aimed at determining the physical and neurological impact of simple exercise on Parkinson's patients.

4 Dec 2009

AclarusDx Alzheimer’s test now available as RUO product

ExonHit Therapeutics is pleased to announce that AclarusDx™ Alzheimer’s test (formerly known as EHT Dx21), its blood-based test for the detection of Alzheimer’s disease (AD), is now available as a Research Use Only (RUO) product for pharmaceutical companies and leading academic centers conducting clinical trials in Alzheimer’s disease.

3 Dec 2009

StemCyte concludes exclusive license and commercialization agreement with Academia Sinica

StemCyte, Inc. concluded an exclusive license and commercialization agreement with Academia Sinica, the National Laboratory of Taiwan, for certain proprietary methods and Intellectual Property (IP) related to the treatment of Chronic Stroke with stem cells.

1 Dec 2009

Free medications to people after heart attack will increase length of their life

Providing free medications to people after heart attack could add years to patients' lives at a relatively low cost for provincial governments, according to a new study by researchers at St. Michael's Hospital in Toronto.

1 Dec 2009

Study examines role of low-oxygen exposure in heart failure patients

Distance runners who live at high altitudes with low oxygen levels are known to improve their performance during races in areas that are at sea level. Can heart failure patients, who suffer from fatigue, improve their exercise performance by staying in a tent-like, high-altitude simulator?

1 Dec 2009

University of Navarra Hospital launches clinical trials to assess the efficacy of immunotherapy treatment

The University of Navarra Hospital has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines -produced from healthy and tumour cells from the patient him or herself- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumours.

1 Dec 2009

Centura Health establishes comprehensive trauma system across its regional facilities

According to the Colorado Department of Public Health and Environment, trauma is the leading cause of death for Coloradans ages one to 44. Studies indicate that 30 to 40 percent of all trauma deaths occur within one hour of injury, and that 30 to 40 percent of these deaths are preventable if timely, appropriate care is received.

1 Dec 2009